Literature DB >> 3355797

In vivo studies on the relationship between intestinal iron (Fe3+) absorption, hypoxia and erythropoiesis in the mouse.

K B Raja1, R J Simpson, M J Pippard, T J Peters.   

Abstract

The effect of hypoxia and changes in erythropoiesis on the absorption of 59Fe3+ from in situ tied-off duodenal segments was studied in the mouse. Hypoxia led to an increase in mucosal uptake within 6 h, whilst mucosal transfer was unaffected for about 20 h, suggesting independent regulation of these two processes. Hypoxia (3 d) stimulated erythropoiesis and resulted in a 2-3-fold increase in the total mucosal uptake of 59Fe. Conversely, hyperoxia (100% O2) caused a decrease in reticulocyte counts and the total mucosal uptake. The changes in the transfer of 59Fe from the mucosa to the body were more marked than changes in uptake in both hypoxia and hyperoxia. Mice subjected to subtotal nephrectomy showed a normal increase in the total mucosal uptake of 59Fe3+ following hypoxic exposure, despite the absence of any changes in the reticulocyte count. Obliteration of the erythroid tissue of animals by splenectomy and 89Sr treatment was accompanied by a marked decrease in the transfer of 59Fe from mucosa to the carcass. However, exposure of splenectomized 89Sr-treated mice to hypoxia resulted in an increase in the total mucosal uptake and carcass transfer of 59Fe, without any change in erythropoiesis. These results indicate that hypoxia enhances mucosal iron uptake by a mechanism which is independent of stimulated erythropoiesis, but that changes in the rate of erythropoiesis have an additional effect, particularly on the transfer phase of iron absorption.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355797     DOI: 10.1111/j.1365-2141.1988.tb04217.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

Review 1.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

2.  Effect of hypoxic exposure on iron absorption in heterozygous hypotransferrinaemic mice.

Authors:  R J Simpson
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

Review 3.  The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions.

Authors:  Maria Mastrogiannaki; Pavle Matak; Carole Peyssonnaux
Journal:  Blood       Date:  2013-05-15       Impact factor: 22.113

4.  Localisation of divalent metal transporter 1 (DMT1) to the microvillus membrane of rat duodenal enterocytes in iron deficiency, but to hepatocytes in iron overload.

Authors:  D Trinder; P S Oates; C Thomas; J Sadleir; E H Morgan
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

5.  Normal iron metabolism and the pathophysiology of iron overload disorders.

Authors:  Chiang W Siah; John Ombiga; Leon A Adams; Debbie Trinder; John K Olynyk
Journal:  Clin Biochem Rev       Date:  2006-02

Review 6.  Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

7.  Duodenal cytochrome b (Cybrd 1) and HIF-2α expression during acute hypoxic exposure in mice.

Authors:  Gladys O Latunde-Dada; Lan Xiang; Robert J Simpson; Andrew T McKie
Journal:  Eur J Nutr       Date:  2011-02-27       Impact factor: 5.614

8.  Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat.

Authors:  M A Barrand; B A Callingham
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

Review 9.  Mechanistic and regulatory aspects of intestinal iron absorption.

Authors:  Sukru Gulec; Gregory J Anderson; James F Collins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-03       Impact factor: 4.052

10.  HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice.

Authors:  Maria Mastrogiannaki; Pavle Matak; Brian Keith; M Celeste Simon; Sophie Vaulont; Carole Peyssonnaux
Journal:  J Clin Invest       Date:  2009-04-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.